Back to dashboard
Medicare AdvantageCoverageMedium impact

Updated Preventive Coverage for Colorectal Cancer Screening to add Colosense® for Medicare Advantage Members (Effective June 8, 2026).

Independence Blue Cross·Gastroenterology, Internal Medicine, Family Medicine·News & Announcements
Effective date
Jun 8, 2026
We identified it
Jul 1, 2026
Days to comply

Summary

Medicare Advantage plans are expanding preventive colorectal cancer screening coverage to include Colosense® (a non-invasive screening technology) effective June 8, 2026. Billing teams must recognize this as a covered preventive service and ensure proper coding and billing without patient cost-sharing.

Action Required

Action needed
By June 8, 2026: Billing team must update billing system and encounter forms to recognize Colosense® as a covered preventive colorectal cancer screening service for Medicare Advantage members. Ensure no patient cost-sharing (copay/deductible) is applied to this service when billed as preventive care. Verify claim submission rules with affected Medicare Advantage plans to confirm proper coding methodology for this new service. Update provider education materials to inform clinical staff of the coverage expansion. Failure to properly bill this as preventive coverage may result in inappropriate patient charges and claim denials.